查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1705991

肠外营养市场：依营养类型、依病患类型、依应用、依通路、按地区

Parenteral Nutrition Market, By Nutrition Type, By Patient Type, By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球肠外营养市场价值估计为 45.543 亿美元，预计到 2032 年将达到 69.393 亿美元。预计 2025 年至 2032 年期间的年复合成长率(CAGR)为 6.2%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 45.543亿美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 6.20% 2032年价值预测 6,939 百万美元
数字。 2025年各地区肠外营养市场占有率（%）
肠外营养市场-IMG1

肠外营养（通常称为全肠外营养）是透过静脉（静脉注射）给予的特殊形式食物的医学术语。治疗的目的是矫正或预防营养不良。肠外营养提供液体营养素，如碳水化合物、蛋白质、脂质、维生素、矿物质和电解质。有些人使用肠外营养，透过放置在胃或小肠中的管子来获取营养（肠外营养），而其他人则单独使用肠外营养。当患者的消化器官系统无法透过口腔吸收或耐受足够量的食物时，可使用肠外营养。在医院外使用静脉营养时，称为家庭肠外营养。家庭肠外营养可能需要持续数週、数月甚至终生。导管感染是肠外营养的常见且严重的併发症。肠外营养的其他潜在短期併发症包括血栓、液体和矿物质失衡以及血糖代谢问题。

市场动态：

近年来，由于导致营养不良的慢性病盛行率不断上升，全球肠外营养市场经历了显着增长。当口服或肠内途径不可行时，肠外营养是指透过静脉导管将营养素直接输送到血液中。肠外营养广泛应用于癌症、胃肠道疾病、肝病和其他慢性疾病的营养不良患者的治疗。此外，老年人口的不断增长，导致消化器官系统较弱、更容易营养不良，这也导致对肠外製剂的需求不断增长。各市场参与企业正致力于开发创新的肠外营养解决方案，以满足该病患小组的治疗需求。然而，肠外营养的高成本对其广泛应用构成了重大挑战。

本研究的主要特点

  • 本报告对全球肠外营养市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球肠外营养市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球肠外营养市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过分析全球肠外营养市场所使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 主要市场参与者之间的合作增强
    • 缺乏对医疗保健、食品和适当营养的意识
    • 增强型肠外营养解决方案的出现
  • 主要亮点
  • 监管情景
  • 市场趋势
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 流行病学
  • 主要市场参与者的新投资
  • 定价分析
  • 合併、收购和合作

4. 全球肠外营养市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球肠外营养市场（依营养类型），2020-2032 年

  • 碳水化合物
  • 脂质乳剂
  • 维生素和微量矿物质
  • 蛋白质
  • 其他（胺基酸等）

6. 2020 年至 2032 年按病患类型分類的全球肠外营养市场

  • 婴儿
  • 成人
  • 老年人

7. 全球肠外营养市场（按应用）2020-2032

  • 糖尿病
  • 肾衰竭
  • 肌少症
  • 癌症
  • 其他（消化系统疾病、METABOLIC INC.症候群等）

8. 全球肠外营养市场（依通路划分），2020-2032 年

  • 医院药房
  • 零售药局
  • 网路药局

9. 全球肠外营养市场（按地区划分），2020-2032 年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

第 11 章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4804

Global Parenteral Nutrition Market is estimated to be valued at USD 4,554.3 Mn in 2025 and is expected to reach USD 6,939. Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4,554.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 6,939. Mn
Figure. Parenteral Nutrition Market Share (%), By Region 2025
Parenteral Nutrition Market - IMG1

Parenteral nutrition, often called total parenteral nutrition, is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to correct or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. People whose digestive systems either can't absorb or can't tolerate adequate food eaten by mouth use parenteral nutrition. When used outside the hospital, intravenous feeding is called home parenteral nutrition. Using home parenteral nutrition may be necessary for weeks or months, or in some cases for life. Catheter infection is a common and serious complication of parenteral nutrition. Other potential short-term complications of parenteral nutrition include blood clots, fluid and mineral imbalances, and problems with blood sugar metabolism.

Market Dynamics:

The global parenteral nutrition market has been witnessing significant growth in the recent past owing to the rising prevalence of chronic diseases inducing malnutrition. Parenteral nutrition entails delivering nutrients directly into the bloodstream through an intravenous catheter when oral or enteral routes are not feasible. It finds wide application in treating malnourished patients suffering from cancer, gastrointestinal disorders, liver diseases, and other chronic conditions. Furthermore, the growing geriatric population who are more susceptible to malnutrition due to weak digestive system has also contributed to the rising demand for parenteral formulations. Various market players are engaged in developing innovative parenteral nutrition solutions to meet the treatment demands of such patient groups. However, high costs associated with parenteral feeding remains a major challenge for widespread adoption.

Key features of the study:

  • This report provides an in-depth analysis of the global parenteral nutrition market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global parenteral nutrition market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include global parenteral nutrition market include AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestle SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global parenteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global parenteral nutrition market.

Detailed Segmentation:

  • Global Parenteral Nutrition Market, By Nutrition Type
    • Carbohydrates
    • Lipid Emulsion
    • Vitamins and Trace Minerals
    • Proteins
    • Others (Amino acids, etc.)
  • Global Parenteral Nutrition Market, By Patient Type
    • Infants
    • Adults
    • Geriatric
  • Global Parenteral Nutrition Market, By Application
    • Diabetes
    • Renal Failures
    • Obesity
    • Sarcopenia
    • Cancer
    • Others (Digestive disorders, Metabolic Syndromes, etc.)
  • Global Parenteral Nutrition Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Parenteral Nutrition Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Nutrition Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing collaborations by key market players
    • Lack of awareness regarding healthcare, diet, and proper nutrition
    • Emergence of enhanced parenteral nutrition solutions
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • New Investments by Major Market Players
  • Pricing Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Parenteral Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Parenteral Nutrition Market, By Nutrition Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Carbohydrates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Lipid Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Vitamins and Trace Minerals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others (Amino acids, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Parenteral Nutrition Market, By Patient Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Parenteral Nutrition Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Renal Failures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Sarcopenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others (Digestive disorders, Metabolic Syndromes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Parenteral Nutrition Market, By Distribution Channel, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

9. Global Parenteral Nutrition Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profile
    • AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danone
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Fresenius Kabi AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GENTAG, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us